| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.097 | 0.08 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.046 | 0.4 |